NCT01898689View on ClinicalTrials.gov

Optimizing Local Anesthetic Concentration for Continuous Popliteal-Sciatic Nerve Blocks

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Relatively Healthy Volunteers
Interventions
DRUG

Ropivacaine 0.1%

A sciatic catheter was inserted and ropivacaine 0.1% was administered as a basal infusion for 6 hours.

DRUG

Ropivacaine 0.4%

A sciatic catheter was inserted and ropivacaine 0.4% was administered as a basal infusion for 6 hours.

Trial Locations (1)

92103

University California San Diego, San Diego

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

University of California, San Diego

OTHER

NCT01898689 - Optimizing Local Anesthetic Concentration for Continuous Popliteal-Sciatic Nerve Blocks | Biotech Hunter | Biotech Hunter